Effects of melatonin administration on the clinical course of adrenocortical disease in domestic ferrets
- PMID: 17144819
- DOI: 10.2460/javma.229.11.1743
Effects of melatonin administration on the clinical course of adrenocortical disease in domestic ferrets
Abstract
Objective: To evaluate the effect of oral administration of melatonin on clinical signs, tumor size, and serum steroid hormone concentrations in ferrets with adrenocortical disease.
Design: Noncontrolled clinical trial.
Animals: 10 adult ferrets with clinical signs of adrenocortical disease (confirmed via serum steroid hormone concentration assessments).
Procedures: Melatonin (0.5 mg) was administered orally to ferrets once daily for 1 year. At 4-month intervals, a complete physical examination; abdominal ultrasonographic examination (including adrenal gland measurement); CBC; serum biochemical analyses; and assessment of serum estradiol, androstenedione, and 17alpha-hydroxyprogesterone concentrations were performed. Serum prolactin and dehydroepiandrosterone sulfate concentrations were evaluated at the first, second, and last examinations, and serum cortisol concentration was evaluated at the first and last examinations.
Results: Daily oral administration of melatonin greatly affected clinical signs of adrenocortical disease in ferrets; changes included hair regrowth, decreased pruritus, increased activity level and appetite, and decreased vulva or prostate size. Mean width of the abnormally large adrenal glands was significantly increased after the 12-month treatment period. Recurrence of clinical signs was detected in 6 ferrets at the 8-month evaluation. Compared with pretreatment values, serum 17alpha-hydroxyprogesterone and prolactin concentrations were significantly increased and decreased after 12 months, respectively.
Conclusions and clinical relevance: Results suggest that melatonin is a useful, easily administered, palliative treatment to decrease clinical signs associated with adrenocortical disease in ferrets, and positive effects of daily treatment were evident for at least an 8-month period. Oral administration of melatonin did not decrease adrenal gland tumor growth in treated ferrets.
Similar articles
-
Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism.J Am Vet Med Assoc. 1996 Sep 15;209(6):1097-102. J Am Vet Med Assoc. 1996. PMID: 8800255
-
Hyperadrenocorticism associated with adrenocortical tumor or nodular hyperplasia of the adrenal gland in ferrets: 50 cases (1987-1991).J Am Vet Med Assoc. 1993 Jul 15;203(2):271-5. J Am Vet Med Assoc. 1993. PMID: 8407489
-
Assessment of cytologic evaluation of preputial epithelial cells as a diagnostic test for detection of adrenocortical disease in castrated ferrets.Am J Vet Res. 2009 May;70(5):619-23. doi: 10.2460/ajvr.70.5.619. Am J Vet Res. 2009. PMID: 19405901
-
Advanced diagnostic approaches and current medical management of insulinomas and adrenocortical disease in ferrets (Mustela putorius furo).Vet Clin North Am Exot Anim Pract. 2010 Sep;13(3):439-52. doi: 10.1016/j.cvex.2010.05.002. Vet Clin North Am Exot Anim Pract. 2010. PMID: 20682429 Review.
-
Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse.Vet Pathol. 2006 Mar;43(2):97-117. doi: 10.1354/vp.43-2-97. Vet Pathol. 2006. PMID: 16537928 Review.
Cited by
-
The senior ferret (Mustela putorius furo).Vet Clin North Am Exot Anim Pract. 2010 Jan;13(1):107-22. doi: 10.1016/j.cvex.2009.12.002. Vet Clin North Am Exot Anim Pract. 2010. PMID: 20159545 Free PMC article. Review.
-
Emergency medicine of the ferret.Vet Clin North Am Exot Anim Pract. 2007 May;10(2):463-500. doi: 10.1016/j.cvex.2007.02.002. Vet Clin North Am Exot Anim Pract. 2007. PMID: 17577560 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources